U.S. Marine and Shipping Stock News

FDA extends Priority Review for Savara’s molgramostim BLA in autoimmune PAP by three months following a major amendment. Regulator cites no new safety, efficacy, or manufacturing concerns in connection with the extension. Extension reflects ongoing review activity for Savara’s lead product candidate, ticker NasdaqGS:SVRA. Savara, listed on NasdaqGS:SVRA, focuses on therapies for rare respiratory diseases, with molgramostim as its most advanced program targeting autoimmune pulmonary alveolar...

If you are wondering whether CNO Financial Group's current share price reflects its true worth, you are not alone. This article focuses squarely on what the numbers say about value. The stock most recently closed at US$43.71, with returns of 0.2% over 7 days, 7.6% over 30 days, 3.6% year to date, 12.3% over 1 year, 106.9% over 3 years and 90.8% over 5 years. This provides plenty of history to measure current pricing against. Recent coverage around CNO Financial Group has centered on its role...

Vail Resorts (NYSE:MTN) reports that an unusually warm winter and record low snowfall have sharply reduced skier visits across its resorts. The company now expects full year results to come in near the lower end of its previously issued guidance. Weather driven disruption to skier visitation is creating a material headwind for resort revenue and in resort spending. For investors watching Vail Resorts, the operational setback comes on top of a weak share price backdrop. NYSE:MTN closed at...

If you are wondering whether ANI Pharmaceuticals at around US$78.64 is priced attractively or already reflects a lot of optimism, the starting point is to understand what the current share price implies about future expectations. The stock shows mixed recent returns, with a 2.8% decline over 7 days, a 6.2% gain over 30 days, a 0.3% return year to date, 12.6% over 1 year, 108.5% over 3 years and 136.3% over 5 years. Recent coverage around ANI Pharmaceuticals has focused on its position within...

If you are wondering whether TransMedics Group at around US$110.93 is still priced attractively or already baking in a lot of optimism, this article walks through the key valuation clues. The stock has had a mixed recent run, with a 4.3% pullback over the last 7 days, an 8.5% gain over 30 days, a 9.6% decline year to date, an 18.6% return over the past year, and a very large 3 year gain of around 40.2%. Recent headlines around TransMedics Group have continued to focus on its position in the...

Hong Leong Bank recently announced a partnership with Tencent Music Entertainment Group’s JOOX and QQ Music to co-present the AsiaTop Music Festival 2026, held on 30 and 31 May 2026 at Malaysia’s Sepang International Circuit with leading Malaysian, Asian and K‑pop acts and exclusive privileges for its cardholders. This collaboration ties Tencent Music’s platforms more closely to offline fan experiences and financial services, potentially deepening regional brand reach and user engagement...

Innovative Aerosystems has acquired an exclusive perpetual license from Honeywell International (NasdaqGS:HON) for aircraft power generating systems. The transaction covers customer contracts, intellectual property rights, and both OEM and aftermarket assets tied to these systems. This move reshapes how Honeywell participates in aircraft power technologies across commercial and defense programs. For you as an investor, this is a focused portfolio move within Honeywell's aerospace business...

Philip Morris International Inc. reported past first-quarter 2026 results with revenue rising to US$10.15 billion from US$9.30 billion, while net income and diluted EPS from continuing operations eased to US$2.44 billion and US$1.56 respectively, and it updated full-year 2026 EPS guidance to US$7.56–US$7.71. Beyond the headline numbers, the quarter underscored how growth in smoke-free products like IQOS and VEEV, supported by pricing power, is reshaping Philip Morris International’s earnings...

How Tripadvisor’s Recent Performance Frames Today’s Valuation Debate Tripadvisor (TRIP) is back on many watchlists after a mixed run, with the share price up over the past month but lower across the past 3 months and year to date. Investors are weighing that pattern against the company’s latest fundamentals. See our latest analysis for Tripadvisor. At a share price of US$11.19, Tripadvisor’s recent pattern shows a strong 30 day share price return of 17.67% alongside a weaker 90 day share...

If you are wondering whether Viking Holdings at US$81.82 is still reasonably priced after a strong run, the key question is how that share price compares with the company’s underlying value. The stock has seen a 13.2% return year to date and a 101.8% return over the last 1 year, with a recent 9.8% move over 30 days followed by a 4.6% pullback over the past week, which can change how investors think about both upside potential and risk. Recent coverage has focused on Viking Holdings as a...

Wondering if Axsome Therapeutics at around US$185.96 is offering fair value or stretching expectations? This breakdown will help you frame what the current price might be implying. The stock has seen a 14.9% return over the last 30 days and a 75.0% return over the last year. The year to date return sits at 4.1%, while the 7 day return is a 1.6% decline. Recent headlines around Axsome have focused on the company as a higher profile name within pharmaceuticals and biotech. This helps explain...

Doximity stock performance sets the stage for closer investor attention Doximity (DOCS) has seen mixed share performance recently, with a modest 1 day gain of 3.6% alongside negative returns over the past month, past 3 months, year to date, and the past year. See our latest analysis for Doximity. With the share price at $24.01, the recent 3.6% one-day share price gain contrasts with a 90-day share price return of a 40.9% decline and a 1-year total shareholder return of a 57.6% decline,...

Dave has rolled out new AI products, CashAI and DaveGPT, as part of its core digital banking and lending offering. The company is pairing this AI launch with a focus on triple digit earnings growth, which is drawing increased investor attention. These developments come as Dave's share price sits at $274.56 under the ticker NasdaqGM:DAVE. For investors tracking NasdaqGM:DAVE, the AI rollout is arriving after a sharp share price move that has already put the company on many watchlists. The...

Instacart, listed as NasdaqGS:CART under Maplebear, has announced the acquisition of Instaleap. Instaleap operates a fulfillment and enablement platform across roughly 30 countries outside North America. The deal is intended to expand Instacart's enterprise services across Europe, Latin America, and the Middle East. Instacart's parent company Maplebear, trading at $42.17, is adding Instaleap to widen its international reach beyond its core North American base. The move comes after a 15.9%...

Verisk Analytics (NasdaqGS:VRSK) has agreed to acquire AccuLynx, a SaaS provider in the restoration and repair industry, in a pending US$2.35b deal. The company expects the transaction to support its property estimating solutions and to be accretive by the end of 2026. Recent collaborations include integrations with Roofr Inc. for insurance claim processing and Pilotbird for social media investigative reports. These moves expand Verisk's ecosystem for insurance and claims professionals...

Investor snapshot after recent price moves Newsmax (NMAX) has drawn investor interest after recent share price swings, with the stock closing at $6.23 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Newsmax. The recent 7 day share price return of a 10.36% decline and year to date share price return of a 20.94% decline, alongside a 1 year total shareholder return of a 72.68% decline, point to fading momentum and a market that is reassessing...

Delek Logistics Partners, LP recently declared an increased quarterly cash distribution for the first quarter of 2026 of US$1.13 per common limited partner unit (US$4.52 on an annualized basis), payable on May 11, 2026 to unitholders of record on May 4, 2026. This higher cash distribution highlights management’s focus on returning capital to unitholders, which may influence how investors view the partnership’s cash flow profile and financial resilience. We’ll now examine how this higher...

Activist investor Land & Buildings has criticized Welltower's new executive compensation plan, describing it as unusually aggressive. The investor argues the structure could work against shareholder interests and weaken alignment between management and owners. The dispute focuses on governance and incentives at NYSE:WELL, rather than short term operating performance. For investors watching NYSE:WELL, this governance debate arrives with the shares at $208.75 and with very large longer term...

If you are wondering whether Boston Scientific at around US$62 a share is starting to look appealing on value, or if the price still has more to adjust, this article is for you. The stock has seen a 3.4% decline over the last week, an 11.0% decline over the last month, and year to date is down 34.5% with a 39.1% decline over the last year, even though the 3 year and 5 year returns sit at 19.1% and 42.4% respectively. Recent moves are playing out against a backdrop of ongoing interest in...

SES AI (NYSE:SES) has appointed Yi (Ray) Liu as Chief Financial Officer, following the departure of Jing Nealis. The company is shifting its Korean manufacturing capacity toward drone cell production for the U.S. defense market. SES AI has signed new North American distribution agreements focused on energy storage applications. SES AI, listed on the NYSE under the ticker SES, develops advanced battery technology for electric mobility and energy storage. The company is now pairing a CFO...

Earlier this month, BlackLine announced Agentic Financial Operations, a new AI-driven operating model for finance and accounting, alongside a dedicated New York AI Innovation Hub focused on transparent, auditable automation. The “glass box” architecture, combining Studio360 workflow orchestration with Verity AI agents and a certified system of record, aims to make AI-driven finance processes both highly automated and fully traceable for auditors and CFOs. Next, we’ll examine how BlackLine’s...

Maze Therapeutics (NasdaqGM:MAZE) completed a sizable underwritten public offering of common stock and pre funded warrants. The deal drew significant participation from both new and existing institutional investors. Proceeds are earmarked to advance Maze Therapeutics' research and development programs focused on serious diseases. Maze Therapeutics, trading at a recent share price of $25.81, has experienced sharp share price swings, with a 7 day return of an 8.1% decline and a 30 day return...

Tompkins Financial (TMP) opened 2026 with Q1 results that build on a strong finish to 2025, with trailing 12 month revenue of US$435.1 million and basic EPS of US$11.30 supported by Q4 2025 net income of US$96.2 million on revenue of US$193.8 million. Over the past year, revenue has moved from US$292.6 million to US$435.1 million on a trailing basis while basic EPS climbed from US$4.98 to US$11.30, alongside net profit margin at 37% versus 24.2% the prior year. This sets up a quarter where...

Corcept Therapeutics (CORT) is back in focus after securing FDA approval for Lifyorli in platinum-resistant ovarian cancer and scheduling Phase 3 ROSELLA data for an oral presentation at the 2026 ASCO Annual Meeting. See our latest analysis for Corcept Therapeutics. With Lifyorli’s FDA approval and the upcoming ROSELLA Phase 3 presentation in view, Corcept’s 30-day share price return of 13.81% and year-to-date share price return of 20.58% contrast with a 1-year total shareholder return of...